Press Releases

Health News Posted on Sunday, November 12, 2017

Press Releases »

New Book From Allen Carr's Easyway Teaches How To Successfully Manage Worry & Anxiety

LONDON , November 12, 2017 /PRNewswire/ -- - ' The Easy Way to Mindfulness ' available from 15 November 2017 - # EasywaytoM indfulness   - " I know so many people who have turned their lives around after ...

Read More

National Alliance for Hispanic Health Honors Nation's Veterans with Focus on Dangers of Tobacco Use

Smoking Cessation Services Are Available to All Veterans through the CDC and VA WASHINGTON , Nov. 11, 2017 /PRNewswire-USNewswire/ -- "This Veteran's Day we give thanks to our country's veterans and show reverence for the sacrifices they ...

Read More

ZEISS introduces VERACITY Surgical at AAO 2017

ZEISS introduces cloud-based cataract surgery planning platform, VERACITY Surgical, and announces integration with leading EMRs ...

Read More

First Data for NKTR-214 in Combination with OPDIVO® (nivolumab) for Patients with Stage IV Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancers, Including Patients with PD-L1 Negative Status, Revealed at SITC 2017

Interim data from the dose-escalation phase of the PIVOT-02 trial highlighted as an oral presentation NATIONAL HARBOR, Md., Nov. 11, 2017 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) and Bristol-Myers Squibb (NYSE: BMY) today announced ...

Read More

Columbia Care Commends Governor Cuomo For Adding PTSD To Qualifying Conditions For New York's Medical Marijuana Program

Addition of qualified condition will allow veterans and others suffering from PTSD access to natural treatment option NEW YORK , Nov. 11, 2017 /PRNewswire-USNewswire/ -- New York-based Columbia Care applauds Governor Andrew Cuomo for ...

Read More

Syndax Pharmaceuticals Announces Presentation of Data from Immuno-oncology Clinical Trials at the Society for Immunotherapy of Cancer 32nd Annual Scientific Meeting

- ENCORE 601 data continue to support increased immune responsiveness in both PD-(L)1 refractory and PD-(L)1 naïve NSCLC patients treated with entinostat and KEYTRUDA® (pembrolizumab)- WALTHAM, Mass. , Nov. 11, 2017 /PRNewswire/ -- Syndax ...

Read More
More Press Releases

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.